Healthcare of Ontario Pension Plan Trust Fund Takes $8.89 Million Position in Perrigo Company plc (NYSE:PRGO)

Healthcare of Ontario Pension Plan Trust Fund bought a new position in shares of Perrigo Company plc (NYSE:PRGO - Free Report) during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund bought 339,000 shares of the company's stock, valued at approximately $8,892,000. Healthcare of Ontario Pension Plan Trust Fund owned approximately 0.25% of Perrigo as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Voisard Asset Management Group Inc. raised its holdings in Perrigo by 9.7% during the third quarter. Voisard Asset Management Group Inc. now owns 5,100 shares of the company's stock worth $134,000 after purchasing an additional 450 shares during the last quarter. Creative Planning raised its stake in Perrigo by 3.7% in the 3rd quarter. Creative Planning now owns 18,477 shares of the company's stock valued at $485,000 after purchasing an additional 661 shares during the last quarter. Arizona State Retirement System lifted its holdings in Perrigo by 1.9% in the 2nd quarter. Arizona State Retirement System now owns 37,939 shares of the company's stock valued at $974,000 after purchasing an additional 699 shares in the last quarter. KBC Group NV boosted its stake in shares of Perrigo by 25.1% during the 3rd quarter. KBC Group NV now owns 4,517 shares of the company's stock worth $118,000 after purchasing an additional 905 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Perrigo by 3.3% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 29,083 shares of the company's stock worth $747,000 after buying an additional 923 shares in the last quarter. 95.91% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, Director Katherine C. Doyle sold 8,954 shares of the business's stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $27.30, for a total transaction of $244,444.20. Following the transaction, the director now directly owns 6,009 shares of the company's stock, valued at approximately $164,045.70. The trade was a 59.84 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.70% of the stock is owned by corporate insiders.

Perrigo Trading Down 0.1 %

Perrigo stock traded down $0.02 during midday trading on Friday, reaching $28.54. The stock had a trading volume of 635,469 shares, compared to its average volume of 1,618,648. The stock's 50-day simple moving average is $26.06 and its 200 day simple moving average is $27.06. Perrigo Company plc has a twelve month low of $23.89 and a twelve month high of $34.60. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.77 and a current ratio of 2.56. The stock has a market capitalization of $3.89 billion, a PE ratio of -24.39 and a beta of 0.48.

Perrigo (NYSE:PRGO - Get Free Report) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.81 earnings per share for the quarter, meeting the consensus estimate of $0.81. The business had revenue of $1.09 billion for the quarter, compared to analyst estimates of $1.12 billion. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The company's revenue was down 3.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.64 EPS. Analysts expect that Perrigo Company plc will post 2.56 EPS for the current year.

Perrigo Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Friday, November 29th will be issued a dividend of $0.276 per share. The ex-dividend date of this dividend is Friday, November 29th. This represents a $1.10 annualized dividend and a dividend yield of 3.87%. Perrigo's payout ratio is -94.02%.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the stock. Jefferies Financial Group restated a "hold" rating and set a $30.00 target price (down previously from $50.00) on shares of Perrigo in a research report on Monday, September 23rd. Canaccord Genuity Group reiterated a "buy" rating and issued a $42.00 target price on shares of Perrigo in a research note on Monday, September 30th. Finally, StockNews.com upgraded Perrigo from a "hold" rating to a "buy" rating in a report on Thursday, November 7th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $37.00.

Perrigo Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.